Annual Current Assets
$48.78 M
+$8.63 M+21.51%
December 31, 2021
Summary
- As of February 10, 2025, PHAS annual total current assets is $48.78 million, with the most recent change of +$8.63 million (+21.51%) on December 31, 2021.
- During the last 3 years, PHAS annual current assets has fallen by -$13.84 million (-22.11%).
Performance
PHAS Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Current Assets
$11.56 M
-$16.00 M-58.05%
June 30, 2022
Summary
- As of February 10, 2025, PHAS quarterly total current assets is $11.56 million, with the most recent change of -$16.00 million (-58.05%) on June 30, 2022.
- Over the past year, PHAS quarterly current assets has dropped by -$76.94 million (-86.93%).
Performance
PHAS Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
PHAS Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +21.5% | -86.9% |
| 3 y3 years | -22.1% | -87.8% |
| 5 y5 years | +254.4% | - |
PHAS Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | -76.3% | at low |
| 5 y | 5-year | -38.1% | -17.7% | -86.9% | at low |
| alltime | all time | -38.1% | -92.0% | -87.8% | at low |
PhaseBio Pharmaceuticals Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $11.56 M(-58.1%) |
| Mar 2022 | - | $27.57 M(-43.5%) |
| Dec 2021 | $11.76 M(+15.2%) | $48.78 M(-25.2%) |
| Sep 2021 | - | $65.24 M(-26.3%) |
| Jun 2021 | - | $88.50 M(+0.4%) |
| Mar 2021 | - | $88.16 M(+119.6%) |
| Dec 2020 | $10.21 M | $40.15 M(-19.6%) |
| Sep 2020 | - | $49.95 M(-21.6%) |
| Jun 2020 | - | $63.74 M(-12.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $72.54 M(-8.0%) |
| Dec 2019 | $3.67 M(+822.4%) | $78.82 M(-5.5%) |
| Sep 2019 | - | $83.37 M(-12.1%) |
| Jun 2019 | - | $94.90 M(+75.5%) |
| Mar 2019 | - | $54.08 M(-13.7%) |
| Dec 2018 | $398.00 K(+19.5%) | $62.63 M(+150.8%) |
| Sep 2018 | - | $24.97 M(-12.9%) |
| Jun 2018 | - | $28.66 M(+108.2%) |
| Dec 2017 | $333.00 K(+42.9%) | $13.77 M |
| Dec 2016 | $233.00 K | - |
FAQ
- What is PhaseBio Pharmaceuticals annual total current assets?
- What is the all time high annual current assets for PhaseBio Pharmaceuticals?
- What is PhaseBio Pharmaceuticals annual current assets year-on-year change?
- What is PhaseBio Pharmaceuticals quarterly total current assets?
- What is the all time high quarterly current assets for PhaseBio Pharmaceuticals?
- What is PhaseBio Pharmaceuticals quarterly current assets year-on-year change?
What is PhaseBio Pharmaceuticals annual total current assets?
The current annual current assets of PHAS is $48.78 M
What is the all time high annual current assets for PhaseBio Pharmaceuticals?
PhaseBio Pharmaceuticals all-time high annual total current assets is $78.82 M
What is PhaseBio Pharmaceuticals annual current assets year-on-year change?
Over the past year, PHAS annual total current assets has changed by +$8.63 M (+21.51%)
What is PhaseBio Pharmaceuticals quarterly total current assets?
The current quarterly current assets of PHAS is $11.56 M
What is the all time high quarterly current assets for PhaseBio Pharmaceuticals?
PhaseBio Pharmaceuticals all-time high quarterly total current assets is $94.90 M
What is PhaseBio Pharmaceuticals quarterly current assets year-on-year change?
Over the past year, PHAS quarterly total current assets has changed by -$76.94 M (-86.93%)